We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current WINT market cap is 25.74M. The company's latest EPS is USD -3.9414 and P/E is -1.28.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.65M | -10.81M | -4.19M | -6.76M | -4.69M |
Net Income | -4.06M | -9.69M | -4.11M | -6.6M | -4.43M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 198k | 0 | 0 | 0 | 0 |
Operating Income | -24.89M | -30.32M | -77.28M | -41.33M | -20.6M |
Net Income | -27.48M | -32.57M | -67.64M | -39.21M | -20.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 48.1M | 37.95M | 35.19M | 40.58M | 36.06M |
Total Liabilities | 30.68M | 27.94M | 28.16M | 28.97M | 28.57M |
Total Equity | 17.42M | 10.01M | 7.03M | 11.6M | 7.48M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 118.98M | 112.89M | 74.79M | 37.95M | 32.41M |
Total Liabilities | 44.04M | 43.33M | 32.91M | 27.94M | 29.02M |
Total Equity | 74.94M | 69.55M | 41.88M | 10.01M | 3.39M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.07M | -19.45M | -2.52M | -6.02M | -9.87M |
Investing | 197k | 197k | N/A | N/A | -15k |
Financing | 1.96M | 3.08M | 591k | 11.31M | 11.07M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -24.66M | -25.32M | -23.66M | -19.45M | -13.44M |
Investing | 13.8M | -291k | -279k | 197k | -15k |
Financing | 21.77M | 19.96M | 29.36M | 3.08M | 11.6M |
Market Cap | 25.74M |
Price to Earnings Ratio | -1.28 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 6.03 |
Price to Book Ratio | 7.68 |
Dividend Yield | - |
Shares Outstanding | 5.15M |
Average Volume (1 week) | 43.52k |
Average Volume (1 Month) | 260.89k |
52 Week Change | -81.73% |
52 Week High | 35.10 |
52 Week Low | 4.7772 |
Spread (Intraday) | 0.58 (10.47%) |
Company Name | Windtree Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.windtreetx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions